Skip to content

Pharminent

cropped-ChatGPT-Image-May-28-2026-10_46_23-PM.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Manufacturing
  • AbbVie opts for North Carolina to house $1.4bn manufacturing site
  • Manufacturing

AbbVie opts for North Carolina to house $1.4bn manufacturing site

Pharmaceutical Technology

This Durham-based facility will be AbbVie's first manufacturing site in the state, and will become a centre of excellence for SVP production.

ManufacturingRead full story

pharminent April 23, 2026 (Last updated: April 23, 2026)

Pharmaceutical Technology

This Durham-based facility will be AbbVie’s first manufacturing site in the state, and will become a centre of excellence for SVP production.

ManufacturingRead full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: MSD teams up with Google Cloud on agentic AI transformation
Next: Sanofi receives FDA approval for Tzield in paediatric diabetes

Related Stories

  • Manufacturing

FUJIFILM opens new iPSC facility in Madison, US

pharminent May 21, 2026
  • Manufacturing

Pharma’s manufacturing reconfigurations provide CDMOs with expansion opportunities

pharminent May 12, 2026
  • Manufacturing

Eli Lilly pledges $4.5bn to bolster Indiana-based manufacturing

pharminent May 7, 2026

You May Have Missed

  • Policy / Pricing

Eli Lilly issues data sharing ultimatum to 340B hospitals

pharminent June 2, 2026
  • M&A / Deals

Fulcrum exploring a potential sale after FDA sidelined its sickle cell drug

pharminent June 2, 2026
  • Clinical Data

ASCO 2026: Kelonia presents positive in vivo CAR-T data in multiple myeloma

pharminent June 2, 2026
  • Clinical Data

ASCO26: In vivo oncology approaches continue to show promise

pharminent June 2, 2026
Copyright © 2026 All rights reserved. | ReviewNews by AF themes.